Parents in more permissive marijuana states see less risk for their medically vulnerable teens
Among parents of chronically ill teens, those in states with more permissive marijuana laws perceived less risk from their child using cannabis, and those in recreational-use states were more likely to report their child had tried marijuana.
Quick Facts
What This Study Found
While 89.9% said any marijuana use was risky for their child, 27.9% would approve if prescribed as medicine. Parents reporting decriminalization were more amenable to teen use, less concerned about impact on their child's condition, and more accepting of marijuana as medicine. Parents in legal medical or recreational states were more likely to report their child had tried or regularly used marijuana. Parents in recreational states were paradoxically less likely to agree marijuana has medical benefits for their child.
Key Numbers
595 parents surveyed. 89.9% said use was risky. 27.9% would approve if prescribed. 11.1% reported decriminalization. 35.6% reported legal medical use. 5.7% reported legal recreational use.
How They Did This
Nationally administered web-based survey of 595 parents of adolescents (ages 13-18) with type 1 diabetes, rheumatic disease, or ADHD. Multivariate ordinal logistic regression modeled effects of perceived state cannabis laws on parental views.
Why This Research Matters
Parents of medically vulnerable children face unique decisions about cannabis. Understanding how legal environment shapes their risk perception can inform clinical guidance.
The Bigger Picture
The finding that legal environment changes parental risk perception suggests that legalization has downstream effects on how parents manage their chronically ill children's exposure to cannabis.
What This Study Doesn't Tell Us
Cross-sectional web survey. Parents self-reported their state's legal status (which may not be accurate). Selection bias from web-based recruitment. Three specific conditions may not represent all chronically ill teens.
Questions This Raises
- ?Do changes in parental attitudes translate to actual changes in teen cannabis use?
- ?Should clinicians in legal states proactively discuss cannabis with parents of chronically ill teens?
Trust & Context
- Key Stat:
- 89.9% said use was risky, but 27.9% would approve if prescribed
- Evidence Grade:
- National survey with multivariate analysis, but cross-sectional design and self-reported legal status.
- Study Age:
- 2019 study.
- Original Title:
- Parental views on state cannabis laws and marijuana use for their medically vulnerable children.
- Published In:
- Drug and alcohol dependence, 199, 59-67 (2019)
- Authors:
- Wisk, Lauren E(4), Levy, Sharon(9), Weitzman, Elissa R(5)
- Database ID:
- RTHC-02351
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Do parents of sick kids support medical marijuana?
While 89.9% saw any marijuana use as risky for their chronically ill child, 27.9% would approve if it were prescribed as medicine, and parents in more permissive states were more open overall.
Does legalization affect teen marijuana use?
Parents in states with legal medical or recreational marijuana were more likely to report that their teenager had tried or regularly used marijuana.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-02351APA
Wisk, Lauren E; Levy, Sharon; Weitzman, Elissa R. (2019). Parental views on state cannabis laws and marijuana use for their medically vulnerable children.. Drug and alcohol dependence, 199, 59-67. https://doi.org/10.1016/j.drugalcdep.2018.12.027
MLA
Wisk, Lauren E, et al. "Parental views on state cannabis laws and marijuana use for their medically vulnerable children.." Drug and alcohol dependence, 2019. https://doi.org/10.1016/j.drugalcdep.2018.12.027
RethinkTHC
RethinkTHC Research Database. "Parental views on state cannabis laws and marijuana use for ..." RTHC-02351. Retrieved from https://rethinkthc.com/research/wisk-2019-parental-views-on-state
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.